PFGIA
NVLN

Patriot Financial Group Insurance Agency’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$1K – 1164
2018
Q3 		$1K Buy
+50
New +$177 ﹤0.01% 978
2017
Q2 		– Sell
-50
Closed -$1K – 950
2017
Q1 		$1K Buy
+50
New +$511 ﹤0.01% 809

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patriot Financial Group Insurance Agency's NVLN Position: Q4 2018 in Review

Patriot Financial Group Insurance Agency sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2018, closing a stake of 50 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in NVLN in Q1 2017 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 36 funds tracked by Wall St. Rank hold NVLN as of Q4 2018.

  • Patriot Financial Group Insurance Agency reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2018 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 50 Novelion Therapeutics Inc. Common Shares shares in Q4 2018, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Novelion Therapeutics Inc. Common Shares in Q1 2017 and held it in 2 quarters.
  • Patriot Financial Group Insurance Agency's Novelion Therapeutics Inc. Common Shares position peaked at $1K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2018.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2018, filed 4 Feb 2019.